Early study checks how new drug DA-1229_01 behaves in the body
NCT ID NCT07342062
First seen Jan 16, 2026 · Last updated Jun 21, 2026 · Updated 28 times
Summary
This early-stage trial looked at how the drug DA-1229_01 is absorbed and processed in 36 healthy adults when taken with food. Participants received a single dose of the drug in two different forms to compare their safety and levels in the blood. The study is complete and focused on gathering basic information, not on treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bumin hospital
Seoul, South Korea
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DA-1229_01 (a drug being tested for how the body processes it)
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.